Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Calcimedica Inc (CALC)

Calcimedica Inc (CALC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 89,768
  • Shares Outstanding, K 14,409
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,700 K
  • EBIT $ -25 M
  • EBITDA $ -25 M
  • 60-Month Beta 0.58
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.46
  • Number of Estimates 2
  • High Estimate -0.44
  • Low Estimate -0.47
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -35.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.92 +58.93%
on 11/28/25
7.20 -13.47%
on 12/26/25
+2.13 (+51.95%)
since 11/26/25
3-Month
2.95 +111.19%
on 11/04/25
7.20 -13.47%
on 12/26/25
+3.15 (+102.27%)
since 09/26/25
52-Week
1.42 +338.73%
on 06/30/25
7.20 -13.47%
on 12/26/25
+3.22 (+106.98%)
since 12/26/24

Most Recent Stories

More News
CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Enrollment ongoing in Phase 2 KOURAGE trial of Auxoraâ„¢ in acute kidney injury (AKI) with respiratory failure; data expected in 1H 2026

CALC : 6.23 (+0.32%)
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension

Preclinical data support CRAC channel inhibitor, CM5480, as a potential first-in-class, differentiated therapy for pulmonary arterial hypertension (PAH), both as monotherapy and in combination with existing...

CALC : 6.23 (+0.32%)
CalciMedica Presents Data from Preclinical Study of Auxoraâ„¢ in an Animal Model of AKI at ASN Kidney Week 2025

Treatment with Auxora significantly reduced IL-17–related inflammation in both kidney and lung, significantly increased glomerular filtration rate (GFR), and decreased renal injury in a rat model of...

CALC : 6.23 (+0.32%)
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxoraâ„¢

AI tools will allow CalciMedica to analyze Phase 2 datasets to refine the target patient populations and efficacy endpoints for upcoming pivotal trials

CALC : 6.23 (+0.32%)
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

LA JOLLA, Calif. , Sept. 2, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel...

CALC : 6.23 (+0.32%)
Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks

Insiders are buying stocks like LLY, TFX, and CALC. The question is whether they are also a good buy for investors, and not all of them are.

TFX : 122.76 (+0.35%)
LLY : 1,077.75 (+0.07%)
CALC : 6.23 (+0.32%)
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Enrollment ongoing in Phase 2 KOURAGE trial of Auxora™ in acute kidney injury (AKI) with respiratory failure; data expected in early 2026 

CALC : 6.23 (+0.32%)
Insider Purchase: Director at $CALC (CALC) Buys 4,800 Shares

FRED A MIDDLETON, a director at $CALC ($CALC), bought 4,800 shares of the company on 12-06-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their...

CALC : 6.23 (+0.32%)
Insiders Bet Big on These Small Cap Stocks

Insiders are buying stocks like CalciMedica and BKV Corporation because they have value and catalysts in 2025 to drive higher share prices.

CALC : 6.23 (+0.32%)
BKV : 27.27 (-0.37%)
CalciMedica Announces Upcoming Presentations and Events in September

/PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium...

CALC : 6.23 (+0.32%)

Business Summary

CalciMedica Inc. is a clinical-stage biopharmaceutical company. It focused on developing therapies for life-threatening inflammatory diseases with high unmet need. CalciMedica Inc. is based in LA JOLLA, Calif.

See More

Key Turning Points

3rd Resistance Point 8.49
2nd Resistance Point 7.84
1st Resistance Point 7.04
Last Price 6.23
1st Support Level 5.59
2nd Support Level 4.94
3rd Support Level 4.14

See More

52-Week High 7.20
Last Price 6.23
Fibonacci 61.8% 4.99
Fibonacci 50% 4.31
Fibonacci 38.2% 3.63
52-Week Low 1.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar